- Research identifies sildenafil as candidate drug for Alzheimer’s disease. Scientists examined the impact of over 1,600 FDA-approved drugs on the various proteins involved with AD, and found that sildenafil was the most effective at disrupting the interaction between amyloid and tau proteins. https://www.eurekalert.org/news-releases/936613 10 comments science
Linking pages
Linked pages
Related searches:
Search whole site: site:www.eurekalert.org
Search title: Cleveland Clinic research identifies sildenaf | EurekAlert!
See how to search.